Oncology Information Systems Market Analysis: Opportunities, Innovations, and Growth Potential Through 2034

The global oncology information systems market was valued at USD 2,951.72 million in 2024 , and it is projected to grow from USD 3,180.48 million in 2025 to USD 6,357.75 million by 2034 , exhibiting a compound annual growth rate (CAGR) of 8.0% during the forecast period (2025–2034) . This steady growth is primarily driven by the increasing incidence of cancer, rising demand for integrated healthcare IT solutions, and growing adoption of digital platforms for precision oncology and treatment monitoring.

Market Definition

Oncology Information Systems (OIS) : Digital platforms designed specifically for managing cancer care across various stages—from diagnosis and treatment planning to patient follow-up and outcome tracking. These systems integrate electronic health record (EHRs), radiation therapy planning, chemotherapy management, and analytics tools to streamline clinical workflows and improve patient outcomes.

Key Report Highlights

• By product & services , the software segment holds the highest market share due to the fundamental need for these solutions in managing core oncology department functionalities, including patient records, treatment planning, and scheduling across various healthcare settings.
• By application , the medical oncology segment commands the largest market share, primarily due to the central and often extensive role of systemic therapies like chemotherapy and immunotherapy in cancer treatment, necessitating comprehensive data management and patient monitoring devices
• By region , North America holds the largest share of the oncology information systems market, attributed to the presence of advanced healthcare infrastructure, high healthcare spending, and early adoption of digital health technologies.
• The Asia Pacific region is projected to experience the highest growth rate in the oncology information systems market over the forecast period, driven by rising cancer prevalence, improving healthcare IT infrastructure, and growing investments in digital transformation. 

Market Overview: Key Figures at a Glance

• Market Value in 2024 : USD 2,951.72 million
• Projected Market Size in 2034 : USD 6,357.75 million
• Anticipated CAGR (2025–2034) : 8.0%

Get access to the full report or request a complimentary sample for in-depth analysis: https://www.polarismarketresearch.com/industry-analysis/oncology-information-systems-market 

Market Growth Drivers

The growth of the oncology information systems market is being fueled by several key factors:

• Rising global incidence of cancer and the need for efficient, data-driven treatment approaches
• Increasing integration of AI, predictive analytics, and cloud-based solutions into oncology workflows
• Growing emphasis on value-based care models that require robust data tracking and reporting
• Expansion of tele-oncology services and remote patient monitoring post-pandemic
• Supportive regulatory frameworks promoting EHR adoption and interoperability in healthcare

Market Key Players

The competitive landscape features a mix of established healthcare IT providers and specialized oncology software developers. Leading companies are investing in innovation, strategic partnerships, and platform enhancements to strengthen their market position. Notable participants include:

• Bogardus Medical Systems
• Elekta AB
• Epic Systems Corporation
• Flatiron Health (F. Hoffmann-La Roche Ltd)
• RaySearch Laboratories AB
• Varian Medical Systems (Siemens Healthineers)